About 1 in 12 men live with color vision deficiency — red and green look nearly identical to them. For most of life, it's an inconvenience. For bladder cancer, new research suggests it can be dangerous.
A Stanford study of 275 million patient records found that people with colorblindness who develop bladder cancer are diagnosed at more advanced stages than those with normal vision. The difference is stark enough that it affects survival rates — a finding that emerged from one of the largest real-world health databases ever assembled.
Why this matters for bladder cancer specifically
Bladder cancer strikes about four times more men than women, and roughly 85,000 Americans were diagnosed in 2025. The disease has a tell: 80 to 90 percent of patients first notice blood in their urine — often before any pain sets in. It's the symptom that prompts a doctor's visit.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxBut if you can't see that blood, you might not notice anything is wrong.
Researchers aren't discovering this connection from scratch. A 2009 study of 200 men with bladder cancer found that colorblind patients were more likely to have invasive disease at diagnosis. Smaller case reports had hinted at the same pattern. What's new is the scale: by searching through de-identified records from roughly 100 million American patients, Stanford researchers identified 135 people with both colorblindness and bladder cancer, then compared them to matched patients with normal vision and the same cancer.
The data was clear. Colorblindness correlated with later diagnosis.
An older experiment showed just how wide the perception gap can be. When shown samples of saliva, urine, and stool, people with normal vision spotted blood nearly every time. Those with colorblindness missed it about one in three times.
The colorectal cancer surprise
Researchers expected to find the same pattern in colorectal cancer — another disease where blood in stool can be a warning sign. They didn't. Among 187 colorblind patients with colorectal cancer, there was no significant survival difference compared to those with normal vision.
The reason points to how differently the two cancers announce themselves. Colorectal cancer rarely leads with blood in the stool. Nearly two-thirds of patients first complain of abdominal pain; over half notice a change in bowel habits. And colorectal cancer screening, recommended for adults 45 to 75, catches many cases before symptoms matter at all.
Bladder cancer, by contrast, often has no other early symptoms. The blood in the urine is the message.
What happens next
Dr. Ehsan Rahimy, who led the research, has already heard from urologists and gastroenterologists — including one who is colorblind himself — that they'd never considered this connection. Some are now asking about color vision during screening appointments.
For people with colorblindness, the practical takeaway is straightforward: get a urine test at every annual checkup. And if you're unsure whether your urine has changed color, ask someone you live with to keep an eye out. It's a small ask that could catch something serious early.
Rahimy frames the study's real value as a starting point. "This is a 30,000-foot view," he said. "When we're seeing certain trends that warrant further investigation, they deserve their own more in-depth analyses." The hope is that awareness spreads quietly — passed along in conversations between doctors and patients, between partners at home — and changes how we screen for cancer in people who see the world differently.
